tiprankstipranks
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
US Market
Holding MGRX?
Track your performance easily

Mangoceuticals, Inc. (MGRX) Income Statement

80 Followers

Mangoceuticals, Inc. Income Statement

Last quarter (Q ), Mangoceuticals, Inc.'s total revenue was $133.37K, a decrease of -5.57% from the same quarter last year. In Q, Mangoceuticals, Inc.'s net income was $-2.00M. See Mangoceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
$ 755.83K$ 731.49K$ 8.94K$ 0.00
Cost of Revenue
$ 311.34K$ 299.99K$ 4.09K$ 0.00
Gross Profit
$ 492.83K$ 431.50K$ 4.85K$ 0.00
Operating Expense
$ 3.51M$ 9.65M$ 2.00M$ 17.52K
Operating Income
$ -8.09M$ -9.22M$ -1.99M$ -17.52K
Net Non Operating Interest Income Expense
--$ -6.47K$ -181.00
Other Income Expense
-$ 6.47K--
Pretax Income
$ -8.56M$ -9.21M$ -2.00M$ -17.70K
Tax Provision
--$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -8.56M$ -9.21M$ -2.00M$ -17.70K
Basic EPS
$ -1.29$ -0.57$ -0.12$ >-0.01
Diluted EPS
$ -1.29$ -0.57$ -0.12$ >-0.01
Basic Average Shares
$ 66.87M$ 16.11M$ 17.32M$ 17.32M
Diluted Average Shares
$ 66.87M$ 16.11M$ 17.32M$ 17.32M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
--$ 0.50-
Reported Normalized Diluted E P S
--$ 0.50-
Rent Expense Supplemental
----
Total Expenses
$ 3.64M$ 9.95M$ 2.00M$ 17.52K
Net Income From Continuing And Discontinued Operation
$ -8.56M$ -9.21M$ -2.00M$ -17.70K
Normalized Income
$ -5.77M$ -7.28M$ -2.00M$ -17.70K
Interest Expense
--$ 6.47K$ 181.00
EBIT
$ -8.30M$ -9.21M$ -1.99M$ -17.52K
EBITDA
$ -7.82M$ -9.19M$ -1.99M$ -17.52K
Currency in USD

Mangoceuticals, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis